R
Ultragenyx Pharmaceutical Inc.RARE
Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease. The company is led by a management team experienced in the development and commercialization of rare disease.
US StocksHealthcareMid CapBiotechnology
Xu hướng giá RARE
Ultragenyx Pharmaceutical Inc. · Biểu đồ TradingView đầy đủ
NASDAQ:RARE